alexa Movement disorders | Switzerland | PDF | PPT| Case Reports | Symptoms | Treatment

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Recommended Conferences

Read more

Recommended Journals

Relevant Topics

Movement Disorders

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
  • Movement disorders

    Pathophysiology:
    Movement disorders are a group of diseases and syndromes affecting the ability to produce and control movement. Sensory information provides critical input on the current position and velocity of body parts, and spinal nerve cells (neurons) help prevent opposing muscle groups from contracting at the same time. To understand how movement disorders occur, it is helpful to consider a normal voluntary movement, such as reaching to touch a nearby object with the right index finger.

  • Movement disorders

    Statistics:

    The prevalence of all common categories of movement disorders was 28.0% (95% CI 25.9-30.1). Proportions in men (27.6% [95% CI 24.5-30.7]) and women (28.3% [25.5-31.2]) were closely similar and sharply increased with age (from 18.5% [15.0-22.0] in 50-59-year olds to 51.3% [44.9-57.7] in 80-89-year olds).

  • Movement disorders

    Treatment:

    Deep brain stimulation (DBS) is a surgical technique which is used for the treatment of Movement disorders in which an electrode (an uninsulated wire) is placed in the subcortical (below the surface) structures of the brain. This electrode is connected to a stimulator (a battery) usually placed near the collarbone.

  • Movement disorders

    Major Research:
    Levodopa: The naturally occurring form of DIHYDROXYPHENYLALANINE and the immediate precursor of DOPAMINE. Unlike dopamine itself, it can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to DOPAMINE. It is used for the treatment of Parkinsonian Disorders and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system.

Expert PPTs

Speaker PPTs

 

High Impact List of Articles

Conference Proceedings

adwords